Reduction of stearoyl-CoA desaturase (SCD) contributes muscle atrophy through the excess endoplasmic reticulum stress in chronic kidney disease.

chronic kidney disease endoplasmic reticulum stress saturated fatty acid skeletal muscle atrophy stearoyl-CoA desaturase

Journal

Journal of clinical biochemistry and nutrition
ISSN: 0912-0009
Titre abrégé: J Clin Biochem Nutr
Pays: Japan
ID NLM: 8700907

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 25 02 2020
accepted: 11 03 2020
entrez: 12 10 2020
pubmed: 13 10 2020
medline: 13 10 2020
Statut: ppublish

Résumé

Skeletal muscle atrophy is associated with mortality and poor prognosis in patients with chronic kidney disease (CKD). However, underlying mechanism by which CKD causes muscle atrophy has not been completely understood. The quality of lipids (lipoquality), which is defined as the functional features of diverse lipid species, has recently been recognized as the pathology of various diseases. In this study, we investigated the roles of the stearoyl-CoA desaturase (SCD), which catalyzes the conversion of saturated fatty acids into monounsaturated fatty acids, in skeletal muscle on muscle atrophy in CKD model animals. In comparison to control rats, CKD rats decreased the SCD activity and its gene expression in atrophic gastrocnemius muscle. Next, oleic acid blocked the reduction of the thickness of C2C12 myotubes and the increase of the endoplasmic reticulum stress induced by SCD inhibitor. Furthermore, endoplasmic reticulum stress inhibitor ameliorated CKD-induced muscle atrophy (the weakness of grip strength and the decrease of muscle fiber size of gastrocnemius muscle) in mice and the reduction of the thickness of C2C12 myotubes by SCD inhibitor. These results suggest that the repression of SCD activity causes muscle atrophy through excessive endoplasmic reticulum stress in CKD.

Identifiants

pubmed: 33041516
doi: 10.3164/jcbn.20-24
pii: DN/JST.JSTAGE/jcbn/20-24
pmc: PMC7533850
doi:

Types de publication

Journal Article

Langues

eng

Pagination

179-187

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL117062
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL132318
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL133545
Pays : United States

Informations de copyright

Copyright © 2020 JCBN.

Déclaration de conflit d'intérêts

No potential conflicts of interest were disclosed.

Références

Nat Rev Mol Cell Biol. 2012 Jan 18;13(2):89-102
pubmed: 22251901
Am J Physiol Cell Physiol. 2018 Jun 1;314(6):C721-C731
pubmed: 29513566
J Lipid Res. 2012 Aug;53(8):1543-52
pubmed: 22628618
Sci Rep. 2017 Feb 02;7:41572
pubmed: 28148966
Am J Physiol Endocrinol Metab. 2014 Sep 15;307(6):E469-84
pubmed: 25096180
J Clin Invest. 2015 Oct 26;125(12):4544-58
pubmed: 26517697
Cell. 2004 Apr 30;117(3):399-412
pubmed: 15109499
Biochim Biophys Acta. 2012 May;1818(5):1309-17
pubmed: 22285120
J Clin Biochem Nutr. 2019 Jul;65(1):23-28
pubmed: 31379410
Prostaglandins Leukot Essent Fatty Acids. 2003 Feb;68(2):113-21
pubmed: 12538075
Am J Physiol Renal Physiol. 2017 Jan 1;312(1):F230-F244
pubmed: 28069662
Biochimie. 2013 Nov;95(11):1971-9
pubmed: 23896376
FEBS J. 2019 Jan;286(2):379-398
pubmed: 29239106
Endocrinology. 2008 May;149(5):2293-305
pubmed: 18202130
J Lipid Res. 1985 Mar;26(3):288-97
pubmed: 3921636
J Clin Biochem Nutr. 2014 Jul;55(1):15-25
pubmed: 25147427
Biochem Biophys Res Commun. 2018 Dec 2;506(4):773-779
pubmed: 30389140
Nat Rev Mol Cell Biol. 2008 Feb;9(2):112-24
pubmed: 18216768
Diabetologia. 2013 Jun;56(6):1372-82
pubmed: 23460021
FASEB J. 2004 Jan;18(1):39-51
pubmed: 14718385
Lipids Health Dis. 2016 Sep 27;15(1):167
pubmed: 27671740
Oxid Med Cell Longev. 2017;2017:2739721
pubmed: 28947926
J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):323-337
pubmed: 30697967
PLoS One. 2019 Dec 31;14(12):e0226940
pubmed: 31891641
J Lipid Res. 2016 Aug;57(8):1329-38
pubmed: 27146479
Nat Rev Nephrol. 2014 Sep;10(9):504-16
pubmed: 24981816
J Biol Chem. 2015 Oct 16;290(42):25497-511
pubmed: 26338703
J Clin Biochem Nutr. 2018 Nov;63(3):181-191
pubmed: 30487667
Physiol Rep. 2017 Dec;5(23):
pubmed: 29199180
Biochem J. 2010 Aug 1;429(3):583-92
pubmed: 20507281
J Clin Biochem Nutr. 2012 Jul;51(1):27-32
pubmed: 22798709
J Ren Nutr. 2013 Mar;23(2):77-90
pubmed: 23428357
Clin Exp Nephrol. 2017 Mar;21(Suppl 1):27-36
pubmed: 27896453

Auteurs

Yuki Niida (Y)

Department of Clinical Nutrition and Food Management, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.

Masashi Masuda (M)

Department of Clinical Nutrition and Food Management, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.

Yuichiro Adachi (Y)

Department of Clinical Nutrition and Food Management, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.

Aika Yoshizawa (A)

Department of Clinical Nutrition and Food Management, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.

Hirokazu Ohminami (H)

Department of Clinical Nutrition and Food Management, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.

Yuki Mori (Y)

Department of Clinical Nutrition and Food Management, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.

Kohta Ohnishi (K)

Department of Clinical Nutrition and Food Management, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.

Hisami Yamanaka-Okumura (H)

Department of Clinical Nutrition and Food Management, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.

Takayuki Uchida (T)

Department of Nutritional Physiology, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.

Takeshi Nikawa (T)

Department of Nutritional Physiology, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.

Hironori Yamamoto (H)

Department of Clinical Nutrition and Food Management, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
Department of Health and Nutrition, Faculty of Human Life, Jin-ai University, 3-1-1 Ohde-cho, Fukui 915-8586, Japan.
Department of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui 910-1193, Japan.

Makoto Miyazaki (M)

Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Denver, Aurora, Colorado 80045, USA.

Yutaka Taketani (Y)

Department of Clinical Nutrition and Food Management, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.

Classifications MeSH